TODAY’S NEWS Big news on the leukemia front: Novartis' Tasigna gets priority FDA review for newly-diagnosed patients; and Roche/Genentech's Rituxan approved for CLL. A quarter of new prescriptions …
August ’08 Pharma News
The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …
Pharma News 2_2
After all that effort with alpha-blockers, beta-blockers, ACE inhibitors, etc....are we just going to circle back to diuretics?? Will Eli Lilly fork over $1,000,000,000 to make Zyprexa marketing …